About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 BuyWrite ETF (NY:IWMW)

39.30 -0.38 (-0.96%)
Official Closing Price Updated: 8:00 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 BuyWrite ETF

< Previous 1 2 3 4 5 Next >
PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance ↗
Via Stocktwits
Atkore Expands Review Process: CEO To Stay On As It Explores Sale Or Merger Options ↗
Via Stocktwits
News headline image
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial ↗
While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) compared to placebo, this trend did not achieve statistical significance, Agios... 
Via Stocktwits
News headline image
Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia ↗
The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Archer Aviation Lands Partnership To Deploy Air Taxi In Saudi Arabia ↗
The partnership will focus on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations. 
Via Stocktwits
Why Did Outset Medical Stock Tumble Today? ↗
Via Stocktwits
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
Via Stocktwits
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗
Via Stocktwits
BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say? ↗
Via Stocktwits
News headline image
Why Did Scholar Rock Soar 26% Today? ↗
The company is planning to reapply for approval of a muscle atrophy therapy in the coming year. 
Via Stocktwits
Topics Earnings
News headline image
Topgolf Callaway Brands Jumps 5% After Report Says Talks Are On To Sell Topgolf Unit ↗
According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion. 
Via Stocktwits
News headline image
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance ↗
The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million. 
Via Stocktwits
Topics Earnings
News headline image
Novavax Sees Higher Revenue From Partners For Full-Year, Raises Revenue Guidance ↗
The company recently expanded on its Sanofi partnership to include its Matrix-M adjuvant in Sanofi’s pandemic influenza vaccine candidate program. 
Via Stocktwits
Intuitive Machines To Acquire Lanteris Space Systems In $800 Million Deal ↗
Via Stocktwits
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors? ↗
Via Stocktwits
Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds ↗
Via Stocktwits
Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report ↗
Via Stocktwits
News headline image
Teladoc Stock Shot Up 8% Today: BofA Views It As Differentiated Asset But Remains Cautious On Near-Term Outlook ↗
BofA’s new price target represents a potential upside of about 5% from the stock’s closing price on Thursday. 
Via Stocktwits
News headline image
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy ↗
CEO Barbara Weber said that across the 16 cancer types enrolled in the trial, the objective response rate (ORR) was 27% in patients with a median follow-up of 9.4 months. 
Via Stocktwits
News headline image
DNUT Stock Trades Above 200-DMA For The First Time Since November 2024 ↗
Morgan Stanley kept its ‘Underweight’ rating and $2.5 price target on Krispy Kreme. 
Via Stocktwits
Topics ETFs
News headline image
Beyond Meat Stock Skyrockets 60% Today: Meme Stock Frenzy Intensifies After ETF Inclusion Amid Surging Retail Buzz ↗
Roundhill Investments said that Beyond Meat has been added to the Roundhill Meme Stock ETF. 
Via Stocktwits
Topics Artificial Intelligence ETFs
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process ↗
Via Stocktwits
Plug Power Names Insider Jose Luis Crespo As New CEO ↗
Via Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals ↗
Via Stocktwits
News headline image
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off? ↗
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing. 
Via Stocktwits
News headline image
Applied Digital Stock Soars 7% Pre-Market On $5B AI Factory Lease With US Hyperscaler ↗
Applied Digital said that this was a nearly 15-year lease agreement to deliver 200 MW of critical IT capacity at Polaris Forge 2. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm ↗
BofA analyst Alexander Perry raised the firm's price target on Polaris to $70 from $60 after the company agreed to sell a majority stake in Indian Motorcycle to California-headquartered private equity... 
Via Stocktwits
News headline image
Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity ↗
Shah Capital currently owns 11.8 million shares or 7.2% of Novavax. 
Via Stocktwits
News headline image
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment ↗
SELLAS said that in a study model, SLS009 monotherapy and the combination prolonged overall survival compared to Venetoclax alone, with a statistically significant difference. 
Via Stocktwits
News headline image
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy ↗
The company said that the decision is based on business and strategic considerations and does not reflect concerns regarding the safety or efficacy profile of Fanskya. 
Via Stocktwits
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.